Cite
HARVARD Citation
Hu, B. et al. (2018). Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma. Leukemia & lymphoma. 59 (4), pp. 863-870. [Online].